To include your compound in the COVID-19 Resource Center, submit it here.

Forma adds $195M cash after Celgene extends collaboration

Forma Therapeutics Inc. (Watertown, Mass.) pocketed $195 million in cash up front after Celgene Corp. (NASDAQ:CELG) exercised a 2014 option to enter a second deal to discover

Read the full 276 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE